CIMAX
Price
$27.93
Change
+$0.01 (+0.04%)
Updated
Sep 11 closing price
Net Assets
149.58B
DPREX
Price
$14.75
Change
+$0.01 (+0.07%)
Updated
Sep 11 closing price
Net Assets
98.76M
Interact to see
Advertisement

CIMAX vs DPREX

CIMAX vs DPREX Comparison Chart in %
View a ticker or compare two or three
VS
CIMAX vs. DPREX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMAX is a Hold and DPREX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMAX has more cash in the bank: 150B vs. DPREX (98.8M). CIMAX pays higher dividends than DPREX: CIMAX (3.36) vs DPREX (2.47). CIMAX was incepted earlier than DPREX: CIMAX (25 years) vs DPREX (31 years). DPREX (1.47) is less costly to investors than CIMAX (0.59). CIMAX is a more actively managed with annual turnover of: 65.00 vs. DPREX (61.00). DPREX initial investment is less costly to investors than CIMAX (4%) vs CIMAX (4%). CIMAX has a lower initial minimum investment than DPREX: CIMAX (250) vs DPREX (1000). DPREX annual gain was more profitable for investors over the last year : 13.58 vs. CIMAX (4.95). CIMAX return over 5 years is better than : 27.94 vs. DPREX (16.72).
CIMAXDPREXCIMAX / DPREX
Total Expense Ratio0.591.1651%
Annual Report Gross Expense Ratio0.591.4740%
Fund Existence25 years31 years-
Gain YTD8.6369.40492%
Front Load4%6%61%
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets150B98.8M151,822%
Annual Yield % from dividends3.362.47136%
Returns for 1 year4.9513.5836%
Returns for 3 years38.4634.50111%
Returns for 5 years27.9416.72167%
Returns for 10 years82.1622.04373%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFLVX68.180.57
+0.84%
DFA US Large Cap Value I
QBNAX39.46N/A
N/A
Pear Tree Polaris Small Cap Instl
OIRDX30.13N/A
N/A
Invesco Rising Dividends R6
GSEUX73.70N/A
N/A
Goldman Sachs US Equity Insights R6
SVXCX92.80N/A
N/A
Smead International Value C